Progression-free survival Radiographic evaluation every 2 months, clinial evaluation every 2 weeks [clinicaltrials_resource:cca8de2cf834839cc83c815cb366751d]

Progression-free survival Radiographic evaluation every 2 months, clinial evaluation every 2 weeks [clinicaltrials_resource:cca8de2cf834839cc83c815cb366751d]

Open-label to Bevacizumab plus mFOLFOX6
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:cca8de2cf834839cc83c815cb366751d
clinicaltrials:NCT00707889
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Progression-free survival Radiographic evaluation every 2 months, clinial evaluation every 2 weeks [clinicaltrials_resource:cca8de2cf834839cc83c815cb366751d]

Open-label to Bevacizumab plus mFOLFOX6
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:cca8de2cf834839cc83c815cb366751d
Bio2RDF identifier
cca8de2cf834839cc83c815cb366751d
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cca8de2cf834839cc83c815cb366751d
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
Radiographic evaluation every 2 months, clinial evaluation every 2 weeks
description
Open-label to Bevacizumab plus mFOLFOX6
identifier
clinicaltrials_resource:cca8de2cf834839cc83c815cb366751d
title
Progression-free survival Radi ...... inial evaluation every 2 weeks
@en
inDataset
type
label
Progression-free survival Radi ...... 8de2cf834839cc83c815cb366751d]
@en